Salspera, Inc.

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://salspera.com/

Last Round

IPO

Feb 2, 2026

Total Funding Raised

$680,000

Company Overview

Salspera, Inc. is a biotechnology company that develops live biopharmaceutical immunotherapies for the treatment of solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

live biopharmaceuticalLBPimmunotherapysolid tumor treatmentcancer immunotherapySalmonella Typhimuriumgenetically modified bacteriatumor microenvironmentinterleukin-2IL-2oncolytic bacteriapancreatic cancerosteosarcomabiotechclinical-stage biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Salspera, Inc. Comparables

Compare Salspera, Inc. with similar companies based on industry and business-model similarity.

Salspera, Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Actym Therapeutics	88%
Prokarium	83%
Tranquility Biodesign	77%

View all Comparables

Salspera, Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
IPO	Feb 2, 2026

View all Funding Rounds

Key People

Founding team and executive leadership

Eddie Moradian

Chief Executive Officer

Executive Team

Salspera, Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Salspera, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Salspera, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range2

Year Founded2017

Last FundingFeb 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.